Variant report
Variant | nsv1051036 |
---|---|
Chromosome Location | chr13:66367207-66385182 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr13:66367393-66367619 | IMR90 | lung: | n/a | n/a |
2 | E2F4 | chr13:66380583-66380641 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr13:66382203-66382600 | HUVEC | blood vessel: | n/a | n/a |
4 | GATA3 | chr13:66380836-66380964 | SH-SY5Y | brain: | n/a | chr13:66380878-66380887 chr13:66380878-66380885 chr13:66380878-66380885 chr13:66380877-66380887 chr13:66380874-66380890 chr13:66380871-66380892 chr13:66380887-66380896 chr13:66380878-66380885 |
5 | IKZF1 | chr13:66371922-66371996 | GM12878 | blood: | n/a | n/a |
6 | JUN | chr13:66382298-66382470 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | MAFF | chr13:66369783-66369995 | HepG2 | liver: | n/a | n/a |
8 | MAFF | chr13:66369836-66369882 | K562 | blood: | n/a | n/a |
9 | MAFK | chr13:66369760-66369880 | Hela-S3 | cervix: | n/a | n/a |
10 | MAFK | chr13:66375627-66375891 | HepG2 | liver: | n/a | chr13:66375732-66375752 |
11 | MAFK | chr13:66369714-66369990 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr13:66369717-66369995 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr13:66369747-66370006 | IMR90 | lung: | n/a | n/a |
14 | MAFK | chr13:66369822-66369829 | K562 | blood: | n/a | n/a |
15 | MAFK | chr13:66375688-66375788 | HepG2 | liver: | n/a | chr13:66375732-66375752 |
16 | MAFK | chr13:66375752-66375843 | IMR90 | lung: | n/a | n/a |
17 | MYC | chr13:66381039-66381040 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | MYC | chr13:66383236-66383252 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | MYC | chr13:66382441-66382626 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | MYC | chr13:66376238-66376307 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | NRF1 | chr13:66370631-66370714 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | POLR2A | chr13:66371597-66371865 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr13:66384177-66384312 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr13:66383074-66383117 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | STAT3 | chr13:66379648-66379666 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | STAT3 | chr13:66369750-66370039 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr13:66382296-66382514 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | TCF7L2 | chr13:66384086-66384397 | HEK293 | kidney: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:66377468..66378968-chr8:43092929..43094908,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HNRNPA3P5 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75029149 | chr13:66367403-66367404 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs568073213 | chr13:66367437-66367438 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs550144686 | chr13:66367450-66367451 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs4884625 | chr13:66367477-66367478 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs535884460 | chr13:66367486-66367487 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs9540556 | chr13:66367525-66367526 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs183965160 | chr13:66367547-66367548 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs539780725 | chr13:66367551-66367552 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs546704683 | chr13:66367614-66367615 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs529853900 | chr13:66372053-66372054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78003290 | chr13:66372062-66372063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560565409 | chr13:66372065-66372066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532680612 | chr13:66372084-66372085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552589505 | chr13:66372108-66372109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569199987 | chr13:66372139-66372140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183206718 | chr13:66372140-66372141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151218735 | chr13:66372146-66372147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57780307 | chr13:66372163-66372164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs66525436 | chr13:66372164-66372165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117127796 | chr13:66372174-66372175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113004146 | chr13:66372183-66372184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568670281 | chr13:66372191-66372192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532193216 | chr13:66372192-66372193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186475009 | chr13:66372222-66372223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2151399 | chr13:66372278-66372279 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs566210371 | chr13:66372316-66372317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191012593 | chr13:66372345-66372346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76863201 | chr13:66372386-66372387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575128499 | chr13:66372413-66372414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575328979 | chr13:66372479-66372480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182722088 | chr13:66372482-66372483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17077666 | chr13:66372497-66372498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540405861 | chr13:66372517-66372518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149523227 | chr13:66372560-66372561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34585602 | chr13:66372574-66372575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577127657 | chr13:66372587-66372588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546292696 | chr13:66372589-66372590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140409535 | chr13:66372614-66372615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372956902 | chr13:66372635-66372636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74704605 | chr13:66372680-66372681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs207473933 | chr13:66372761-66372762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13378526 | chr13:66372776-66372777 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs548336624 | chr13:66372823-66372824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17548600 | chr13:66372837-66372838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144044579 | chr13:66372841-66372842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17077668 | chr13:66372882-66372883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs570681304 | chr13:66372891-66372892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17077670 | chr13:66372935-66372936 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs187717471 | chr13:66372942-66372943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552206854 | chr13:66372960-66372961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66372000-66373600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr13:66373600-66376400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:66376400-66377200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr13:66376600-66377000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr13:66377000-66379000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr13:66377200-66379000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr13:66379000-66379200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:66379000-66379400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr13:66379200-66379600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr13:66379400-66382200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr13:66379600-66379800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr13:66379800-66382400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr13:66380800-66382000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr13:66381000-66382800 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr13:66381000-66382800 | Enhancers | Osteobl | bone |
16 | chr13:66381400-66383200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr13:66381800-66383400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr13:66382000-66382200 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr13:66382200-66382600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr13:66382200-66383000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr13:66382400-66382800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |